Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the…
IQM Announces First U.S. Quantum Technology Center in the University of Maryland’s Discovery District, Joining the Capital of Quantum Ecosystem IQM Quantum Computers, a global leader in superconducting quantum computing, and the Capital of Quantum (CoQ) announced today the establishment…
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen® Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today…
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for biotech and pharma R&D teams,…
Gulf Coast Midstream Partners Secures Investment from Black Bay Partners to Advance the Development of Natural Gas Storage Hub in Southeast Texas Gulf Coast Midstream Partners, LLC a private developer of energy midstream assets, today announced a growth capital investment…
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, announced the…
Ducon Announces Advanced Solutions to Mitigate Air Pollution from Missile Interceptions Ducon Technologies a global leader in high-efficiency air pollution control and infrastructure related technologies, announced solutions for the escalating environmental and public health crisis caused by high-altitude missile interceptions…
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board Harmony Biosciences Holdings, Inc. announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of Troy…
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced that founder Howard Berman,…
CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26 CorVista Health, a leader in noninvasive cardiovascular diagnostics, announced new data evaluating a physiologic signal–based machine-learning model for detecting cardiac ischemia.…
TruArc Partners Acquires North American Adhesives and Sealant Solutions Provider Matrix Adhesives Group TruArc Partners a private equity firm focused on middle-market investments in business services and specialty manufacturing, announced today that it has acquired Matrix Adhesives Group (“Matrix” or…
Ditch Technology Secures Patent on Behavior Based Marine Routing; Offers OEMs a Production Ready Path to a Smarter Helm. Ditch Technology Inc. announced it has secured US Patent No. 12,429,339 for behavior based marine routing and is making its production…